Antibacterial and antibiofilm activity of nanochelating based silver nanoparticles against several nosocomial pathogens
- 28 February 2018
- journal article
- research article
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 32 (5)
Abstract
The emergence of multi‐drug resistant (MDR) bacteria and dynamic pattern of infectious diseases demand to develop alternative and more effective therapeutic strategies. Silver nanoparticles (AgNPs) are among the most widely commercialized engineered nanomaterials, because of their unique properties and increasing use for various applications in nanomedicine. This study for the first time aimed to evaluate the antibacterial and antibiofilm activities of newly synthesized nanochelating based AgNPs against several Gram‐positive and ‐negative nosocomial pathogens.Nanochelating technology was used to design and synthesize the AgNPs. The cytotoxicity was tested in human cell line using the MTT assay. AgNPs minimal inhibitory concentration (MIC) was determined by standard broth microdilution. Antibiofilm activity was assayed by a microtiter‐plate screening method.The two synthesized AgNPs including AgNPs (A) with the size of about 20‐25 nm, and AgNPs (B) with 30‐35 nm were tested against Staphylococcus aureus, Staphylococcus epidermidis, Acinetobacter baumannii, and Pseudomonas aeruginosa. AgNPs exhibited higher antibacterial activity against Gram‐positive strains. AgNPs were found to significantly inhibit the biofilm formation of tested strains in concentration 0.01 to 10 mg/mL. AgNPs (A) showed significant effective antibiofilm activity compared to AgNPs (B).In summary, our results showed the promising antibacterial and antibiofilm activity of our new nanochelating based synthesized AgNPs against several nosocomial pathogens.Keywords
Funding Information
- Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences (7630)
This publication has 33 references indexed in Scilit:
- Novel Strategies for the Prevention and Treatment of Biofilm Related InfectionsInternational Journal of Molecular Sciences, 2013
- Antibiofilm efficacy of silver nanoparticles against biofilm of extended spectrum β-lactamase isolates of Escherichia coli and Klebsiella pneumoniaeApplied Nanoscience, 2013
- The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccineVaccine, 2013
- Cytotoxicity of Biologically Synthesized Silver Nanoparticles in MDA-MB-231 Human Breast Cancer CellsBioMed Research International, 2013
- Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative studyInternational Journal of Nanomedicine, 2012
- Healthcare - associated infections: A public health problemNigerian Medical Journal, 2012
- “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant eraJournal of Controlled Release, 2011
- Hospital-Acquired Infections Due to Gram-Negative BacteriaNew England Journal of Medicine, 2010
- Strain specificity in antimicrobial activity of silver and copper nanoparticlesActa Biomaterialia, 2008
- Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coliNanomedicine: Nanotechnology, Biology and Medicine, 2007